Patents by Inventor Chris ADAIR

Chris ADAIR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11970497
    Abstract: The present invention relates to novel tricyclic compounds that are AKR1C3 dependent KARS inhibitor, processes for their preparation, pharmaceutical compositions, and medicaments containing them, and their use in diseases and disorders mediated by an AKR1C3 dependent KARS inhibitor.
    Type: Grant
    Filed: July 31, 2020
    Date of Patent: April 30, 2024
    Assignee: Novartis AG
    Inventors: Chris Adair, Tracy Chen, Jian Ding, Christy Fryer, Yuko Isome, Marie-Helene Larraufie, Katsumasa Nakajima, Nik Savage, Ariel Sterling Twomey
  • Publication number: 20220315582
    Abstract: The present invention relates to novel tricyclic compounds that are AKR1C3 dependent KARS inhibitor, processes for their preparation, pharmaceutical compositions, and medicaments containing them, and their use in diseases and disorders mediated by an AKR1C3 dependent KARS inhibitor.
    Type: Application
    Filed: July 31, 2020
    Publication date: October 6, 2022
    Inventors: Chris ADAIR, Tracy CHEN, Jian DING, Christy FRYER, Yuko ISOME, Marie-Helene LARRAUFIE, Katsumasa NAKAJIMA, Nik SAVAGE, Ariel Sterling TWOMEY
  • Publication number: 20200170950
    Abstract: Cannabis and cannabis-derived compositions, methods of making and methods of using the compositions in oral dosage forms, such as in beverage forms, are disclosed herein. The compositions comprise a cannabinoid or a cannabis-derived compound, inulin and pectin and may be in powder or liquid form.
    Type: Application
    Filed: November 29, 2019
    Publication date: June 4, 2020
    Inventors: Chris ADAIR, Ben GEILING, Mohammadmehdi Haghdoost MANJILI, Mark ZOLKIEWSKI